Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)
China · Delayed Price · Currency is CNY 30.79
-1.19 (-3.72%)
At close: May 21, 2026
SHE:301290 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | - | 430.47 | 430.5 | 440.73 | 442.57 | 354.91 |
Other Revenue | - | 4.99 | 3.23 | 1.37 | 3.93 | 19.52 |
| 3,939 | 435.46 | 433.73 | 442.1 | 446.5 | 374.43 | |
Revenue Growth (YoY) | 833.85% | 0.40% | -1.89% | -0.98% | 19.25% | 26.67% |
Cost of Revenue | - | 221.08 | 225.86 | 210.6 | 195.33 | 167.82 |
Gross Profit | 441.75 | 214.38 | 207.88 | 231.5 | 251.17 | 206.61 |
Selling, General & Admin | - | 112.72 | 106.62 | 93.08 | 104.58 | 91.48 |
Research & Development | - | 22.43 | 27.11 | 24.21 | 20.67 | 18.32 |
Other Operating Expenses | - | 5.18 | 2.65 | 4.39 | 3.14 | 4.19 |
Operating Expenses | - | 140.77 | 135.94 | 124.56 | 128.17 | 112.8 |
Operating Income | - | 73.6 | 71.94 | 106.94 | 123 | 93.82 |
Interest Expense | -7.07 | -0.34 | -0.06 | -0.13 | -0.11 | -2.3 |
Interest & Investment Income | - | 39.4 | 16.25 | 5.28 | 2.4 | 1.18 |
Currency Exchange Gain (Loss) | - | -0.14 | -0.02 | 0.49 | -0.1 | -0.15 |
Other Non Operating Income (Expenses) | - | -0.1 | -0.05 | -0.28 | -0.34 | -0.3 |
EBT Excluding Unusual Items | 251.17 | 112.42 | 88.05 | 112.3 | 124.85 | 92.25 |
Gain (Loss) on Sale of Investments | - | -7 | 13.69 | 0.5 | - | - |
Gain (Loss) on Sale of Assets | - | -0.09 | -0.59 | -0.43 | -0.25 | -0.13 |
Other Unusual Items | - | 9.73 | 15.91 | 7.44 | 5.33 | 3.51 |
Pretax Income | - | 115.06 | 117.06 | 119.82 | 129.93 | 95.63 |
Income Tax Expense | - | 18.17 | 17.18 | 16.1 | 18.86 | 15.35 |
Earnings From Continuing Operations | 242.55 | 96.89 | 99.88 | 103.72 | 111.07 | 80.28 |
Minority Interest in Earnings | - | 0.53 | -2.66 | -1.21 | -0.82 | -0.57 |
Net Income | 242.56 | 97.42 | 97.22 | 102.51 | 110.25 | 79.7 |
Net Income to Common | - | 97.42 | 97.22 | 102.51 | 110.25 | 79.7 |
Net Income Growth | 170.72% | 0.21% | -5.15% | -7.03% | 38.33% | 68.22% |
Shares Outstanding (Basic) | 99 | 99 | 100 | 77 | 75 | 68 |
Shares Outstanding (Diluted) | 99 | 99 | 100 | 77 | 75 | 68 |
Shares Change (YoY) | -1.00% | -0.81% | 30.05% | 2.76% | 10.45% | 25.21% |
EPS (Basic) | - | 0.98 | 0.97 | 1.33 | 1.47 | 1.17 |
EPS (Diluted) | 0.48 | 0.98 | 0.97 | 1.33 | 1.47 | 1.17 |
EPS Growth | -46.39% | 1.03% | -27.07% | -9.52% | 25.64% | 34.48% |
Free Cash Flow | 1,409 | 10.54 | 51.68 | 20.28 | 67.78 | 88.64 |
Free Cash Flow Per Share | 14.28 | 0.11 | 0.52 | 0.26 | 0.90 | 1.30 |
Dividend Per Share | 0.240 | 0.600 | 0.600 | 0.500 | - | - |
Dividend Growth | -60.00% | - | 20.00% | - | - | - |
Gross Margin | 11.21% | 49.23% | 47.93% | 52.36% | 56.25% | 55.18% |
Operating Margin | - | 16.90% | 16.59% | 24.19% | 27.55% | 25.06% |
Profit Margin | - | 22.37% | 22.41% | 23.19% | 24.69% | 21.29% |
Free Cash Flow Margin | 35.76% | 2.42% | 11.91% | 4.59% | 15.18% | 23.67% |
EBITDA | 344.23 | 115.31 | 109.58 | 141.18 | 150.64 | 117.07 |
EBITDA Margin | 8.74% | 26.48% | 25.26% | 31.93% | 33.74% | 31.27% |
D&A For EBITDA | 85.38 | 41.71 | 37.64 | 34.24 | 27.64 | 23.26 |
EBIT | 258.85 | 73.6 | 71.94 | 106.94 | 123 | 93.82 |
EBIT Margin | 6.57% | 16.90% | 16.59% | 24.19% | 27.55% | 25.06% |
Effective Tax Rate | - | 15.79% | 14.68% | 13.44% | 14.52% | 16.05% |
Revenue as Reported | - | 435.46 | 433.73 | 442.1 | 446.5 | 374.43 |
Advertising Expenses | - | 2.07 | 1.87 | 1.34 | 2.48 | 1.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.